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Abstract: Skeletal muscle is constantly renewed in response to injury, exercise, or muscle diseases. 
Muscle stem cells, also known as satellite cells, are stimulated by local damage to proliferate 
extensively and form myoblasts that then migrate, differentiate, and fuse to form muscle fibers. The 
transmembrane heparan sulfate proteoglycan syndecan-4 plays multiple roles in signal 
transduction processes, such as regulating the activity of the small GTPase Rac1 (Ras-related C3 
botulinum toxin substrate 1) by binding and inhibiting the activity of Tiam1 (T-lymphoma invasion 
and metastasis-1), a guanine nucleotide exchange factor for Rac1. The Rac1-mediated actin 
remodeling is required for cell migration. Syndecan-4 knockout mice cannot regenerate injured 
muscle; however, the detailed underlying mechanism is unknown. Here, we demonstrate that 
shRNA-mediated knockdown of syndecan-4 decreases the random migration of mouse myoblasts 
during live-cell microscopy. Treatment with the Rac1 inhibitor NSC23766 did not restore the 
migration capacity of syndecan-4 silenced cells; in fact, it was further reduced. Syndecan-4 
knockdown decreased the directional persistence of migration, abrogated the polarized, asymmetric 
distribution of Tiam1, and reduced the total Tiam1 level of the cells. Syndecan-4 affects myoblast 
migration via its role in expression and localization of Tiam1; this finding may facilitate greater 
understanding of the essential role of syndecan-4 in the development and regeneration of skeletal 
muscle. 
Keywords: myoblast; cell migration; Tiam1; syndecan-4; proteoglycan; Rac1; NSC23766; directional 
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1. Introduction 
Skeletal muscle is a highly dynamic tissue that can regenerate successfully following injury, and 
it can change in size in response to exercise, aging, or diseases (e.g., cancer cachexia, immobilization, 
muscular dystrophy). The skeletal muscle stem cells, also known as satellite cells, which are localized 
between the muscle fiber and basal lamina, are responsible for the plasticity, maintenance, and 
regeneration of skeletal muscle [1,2]. The satellite cells are mitotically and physiologically quiescent 
in healthy muscle, but they are stimulated by local damage to form myoblasts that subsequently 
proliferate, migrate, differentiate, and fuse to form multinucleated muscle fibers. 
Cell migration is essential for establishing and maintaining the proper organization of 
multicellular organisms [3]. Cell movement is a complex process that plays an important role in 
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various physiological processes including regeneration, wound healing, angiogenesis, embryonic 
development, and immune cell responses, in addition to tumor progression and metastasis 
formation. One of the most important conditions for cell movement is the polarization of the cell, in 
terms of morphology, with the formation of a leading edge at the front and a retracting tail, and the 
correct positioning of the cellular components [4]. An actin-rich protrusion, called the lamellipodium, 
must evolve toward migration, thereby creating asymmetry in the cell, with distinct front-rear 
polarity [5]. Polarization is also defined by the positioning of the cell nucleus and the reorientation of 
the Golgi network and microtubule organizing center toward the leading edge [6,7]. The Rho family 
of small GTPases, including Rac1 (Ras-related C3 botulinum toxin substrate 1), Cdc42, and RhoA, 
plays a fundamental role in the development and maintenance of this front-rear polarity [8]. 
The Rho GTPases act as molecular switches cycling between an inactive GDP-bound and an 
active GTP-bound form to bind and activate downstream effector proteins, thereby affecting various 
signaling pathways [9]. The two-state cycle is regulated by three sets of proteins: the guanine 
nucleotide exchange factors (GEFs), which catalyze the exchange of GDP for GTP, and GTPase-
activating proteins (GAPs), which increase intrinsic GTP hydrolysis, are responsible for Rho GTPases 
switching between their active and inactive forms, respectively. Moreover, switching between GDP- 
and GTP-bound states may involve cytosol-membrane translocation, as guanine dissociation 
inhibitors (GDIs) prevent Rho GTPases from membrane-targeting and activation [10].  
Tiam1 (T-lymphoma invasion and metastasis-1) has been identified as a GEF, acting as a specific 
activator of Rac1 [11], and it plays a key role in pivotal biological processes including cell migration 
[8] and cell polarization [11]. The Par (partitioning defective) polarity complex, comprising Par3, Par6 
and atypical PKC, plays a key role in the development and maintenance of cell polarity [8]. 
Furthermore, Tiam1, along with the Par polarity complex, stimulates persistent migration by 
stabilizing the anterior-posterior polarization of migrating cells [12]. Par3 interacts with Tiam1, 
leading to localized Rac1 activation, creating a gradient of Rac1 and RhoA GTPases in migrating cells: 
the former is concentrated at the leading edge, and the latter is in the rear of the cell [13]. As Tiam1-
mediated Rac1 signaling is required for establishing and maintaining cell polarity [14], impaired 
Tiam1 signaling inhibits the formation of front-rear polarization in migrating cells thereby inhibiting 
persistent migration [12]. 
Syndecan-4 (SDC4) is a ubiquitously expressed transmembrane, heparan sulfate proteoglycan 
that is a major cell surface marker of satellite cells [15]. Syndecan-4 connects the extracellular matrix 
to the cytoskeleton, allowing the interaction between the cell and extracellular matrix components, 
cytokines, or growth factors [16]. The cytoplasmic domain contains one variable and two conserved 
regions, binding to ezrin, radixin, and moesin proteins, in addition to Src kinase, α-actinin, or protein 
kinase C α (PKCα) [17–19], and regulating intracellular Ca2+ concentration [20] or Rac1 activity 
[21,22]. Syndecan-4 binds and inhibits Tiam1, modulating the activity of Rac1 GTPase [22]. The 
cytoplasmic domain of syndecan-4 contains a type II PDZ binding site, and Tiam1 exhibit a PDZ 
domain. Both phosphorylation of the cytoplasmic serine residue of syndecan-4 and the PDZ domain 
binding of Tiam1 are involved in regulation of the GEF activity of Tiam1, thereby regulating Rac1-
GTP level [22].  
Syndecan-4 knockout mice cannot regenerate injured skeletal muscle [23], and the precise 
mechanism underlying this phenomenon is unclear. Given the role of syndecan-4 in the regulation 
of Rac1 GTPase and the importance of cell migration during muscle regeneration, the aim of our 
study was to investigate the role of Tiam1-mediated Rac1 activation in syndecan-4-dependent 
myoblast migration. We have demonstrated that syndecan-4 knockdown decreased migration of 
myoblasts, accompanied by reduced global Tiam1 expression. Moreover, it abrogated the 
asymmetric, polarized distribution of Tiam1 and reduced directional persistence of the movement.  
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2. Results 
2.1. Syndecan-4 Silencing Reduces Myoblast Migration in a Random Migration Assay 
We verified the effect of syndecan-4 (SDC4) silencing by qPCR technique and Western blotting 
in C2C12 mouse myoblast cell lines transfected stably with plasmids expressing shRNA specific for 
syndecan-4 (shSDC4#1 and shSDC4#2), and we also tested the effect of the scrambled sequence [24]. 
The syndecan-4 expression was significantly decreased in both shSDC4#1 and shSDC4#2 cell lines, 
with the reduction being less in the latter; whereas the scrambled sequence did not affect the 
syndecan-4 level [24].  
Initially, the effect of syndecan-4 silencing was examined in a random migration assay for 18 h. 
Representative time-lapse videos are included as Supplemental Videos S1–S4. Syndecan-4 
knockdown significantly reduced the total path of migration, both the vectorial distance (i.e. real shift 
of the cells) and the maximum distance from the origin were decreased; furthermore, the average and 
maximum speed were also reduced (Figure 1A–E). No significant difference was observed between 
the non-transfected and scrambled cells.  
 
Figure 1. The role of syndecan-4 and Rac1 (Ras-related C3 botulinum toxin substrate 1) in random, 
two-dimensional migration of myoblasts. The total length of movement (A), the vectorial distance 
(real displacement of the cells) (B), the maximum distance from the starting point (C), the average cell 
speed (D), and the maximum speed (E) of the cells are depicted in non-transfected, scrambled, and 
syndecan-4 silenced (shSDC4#1, shSDC4#2) C2C12 myoblast cells either without or with NSC23766 
(Rac1 inhibitor) treatment. Schematic representation of the total path, vectorial distance, and 
maximum distance of the movement (F). The total duration of live cell microscopy: 18 h, frame rate: 
3/1 h; n = 4 independent experiments; 62–114 cells/cell line; and 6–8 fields of view/experiment. Data 
are reported means of the independent experiments + SEM; **** p < 0.0001; *** p < 0.001; ** p < 0.01; * p 
< 0.05. 
Next, we transposed the migratory tracks (total paths) of the individual cells to a common origin 
to generate the static wind rose plots depicted in Figure 2. The representative wind rose plots depict 
the migratory tracks of cells based on the position of the x and y coordinates of the movement (Figure 
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2). The smaller diameters of the wind rose plots in both shSDC4#1 and shSDC4#2 lines indicate the 
reduced motility of these cells (Figure 2A).  
2.2. Inhibition of Rac1 Does Not Restore the Defective Migratory Phenotype of Syndecan-4 Knockdown Cells 
Syndecan-4 knockout causes a steady increase in the levels of activated Rac1-GTPase [21,25–28]. 
The aim of our next experiment was to study how Rac1 inhibition affects migration, and whether it 
can improve the decreased migration of syndecan-4 silenced cells. The activity of Rac1 was 
specifically inhibited by NSC23766 treatment [29]. Cell migration was examined for 18 h during a 
random migration assay. Representative time-lapse videos (Supplemental Videos S5–S8) show the 
decreased motility of the cells following NSC23766 treatment. During this analysis, the specific 
inhibition of Rac1 GTPase did not ameliorate the migration defect due to syndecan-4 knockdown. 
Interestingly, Rac1 inhibition caused further significant reduction in all examined parameters, 
including the total path of the cells, vectorial and maximum displacement, and average and 
maximum speed values in all cell lines (Figure 1).  
 
Figure 2. Representative wind-rose plots depict the total path of the cells. The trajectories were shifted 
to a common origin. Each colored line represents the total path of a single untreated myoblast either 
without (A) or with NSC23766 treatment (B) in the different cell lines. Total duration of live cell 
microscopy: 18 h. 
The representative wind rose plots depicting the migratory tracks of the individual cells show 
the decreased motility of all cell lines upon treatment with the Rac1 inhibitor NSC23766 (Figure 2B). 
The representative plots clearly show the result of the combined effect of syndecan-4 silencing and 
Rac1 inhibition. Notably, the migratory parameters of syndecan-4 silenced cell lines further decreased 
following NSC23766 treatment.  
2.3. Syndecan-4 Knockdown Affects the Directional Persistence of Migration 
The effectiveness of cell migration depends on two essential features: cell-speed and directional 
persistence. At the cellular level, directional persistence depends on the tenacity of lamellipodial 
protrusions and the stability of the trailing edge [27,28]. To ascertain the stability of the orientation 
of the cell migration, we also calculated the persistence index [29] in the case of the control and the 
syndecan-4 knockdown cell lines. The values of the persistence index over the timescale represent 
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the time-dependency of the directional persistence showing that these differences can be constantly 
observed by comparing the cell lines (Figure 3A).  
The results show that silencing of syndecan-4 significantly decreases the persistence index of 
myoblasts measured after 18 h movement. There was no significant difference between the non-
transfected and scrambled cell lines. NSC23766 treatment of the cells further reduced persistence 
index in both syndecan-4 knockdown cell lines (Figure 3B). Interestingly, the persistence index of the 
untreated syndecan-4 knockdown cells was similar to the NSC23766-treated control lines; suggesting 
that neither high nor low activity of Rac1 favors directional persistence of the migration.  
 
Figure 3. Directional persistence in cell migration. (A) Average persistence index (vectorial 
distance/total path ratio) over elapsed time indifferent cell lines. (B) Effect of Syndecan-4 (SDC4) 
silencing and/or Rac1 inhibition (NSC23766 treatment, 50 µM) on persistence index after 18 h. n = 4 
independent experiments, 62–114 cells/cell line, 6–8 fields of view/experiment, Data are reported as 
means of the independent experiments + SEM; * p < 0.05; ** p < 0.01. 
2.4. Syndecan-4 Affects Tiam1 Expression and Localization 
As the inhibition of Rac1 activity reduced migration ability (in both control and syndecan-4 
silenced cell lines), we explored whether we could identify alteration in either distribution or 
expression of Tiam1. We found an asymmetrical Tiam1 distribution with an increased intensity 
towards the leading edge in the non-transfected and scrambled cell lines, whereas this peak in the 
Tiam1-intensity was absent in the syndecan-4 silenced cells (Figure 4A). The representative 2D and 
3D pseudocolor images provide better visualization of this altered Tiam1 distribution: the high-
intensity red area depicted an asymmetric Tiam1 enrichment that is mainly adjacent to the nucleus, 
and homogenous cytoplasmic blue-green intensity was observed in both syndecan-4 silenced cell 
lines. These quantified results confirm the pervious observations, as the mean intensity values in the 
individual cells are significantly decreased following syndecan-4 knockdown (Figure 4B), indicative 
of reduced Tiam1 expression in these cells. To measure the variation in the pixel intensities, the 
standard deviation of Tiam1 intensity values within each cell were quantified. The standard deviation 
of intensity values in both syndecan-4 silenced cell lines were significantly lower. The pixel intensity 
values were closer to the mean intensity, whereas they are spread out over a wider range in the 
control cells (Figure 4C).  
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Figure 4. Tiam1 (T-lymphoma invasion and metastasis-1) expression of the different cell lines. (A) 
Representative images show Tiam1 (green) distribution. The non-transfected and scrambled cells 
exhibit an asymmetric, polarized Tiam1 arrangement, which is absent due to SDC4 silencing. Nuclei 
are blue (Hoechst 33258). Representative pseudocolor images (2D and 3D) depict Tiam1 signal 
intensity. The color was assigned to each pixel based on the pixel intensity value according to the 
calibration bar (shown on left-hand sides of the images). The mean intensity values in the individual 
cells are quantified in (B), and the average standard deviation values of the Tiam1 intensities are 
depicted in (C); n = 4–20 cells/cell line were analyzed; data are reported as mean+ SEM; **** p < 0.0001. 
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3. Discussion 
Tiam1 plays an essential role in pivotal biological processes and has been identified as a 
nucleotide exchange factor (GEF), a specific activator of the small GTPase Rac1 [11]; however, it is 
also specific for Cdc42 and to a lesser extent, RhoA [30]. The Par (comprising Par3, Par6, and atypical 
PKC)-Tiam1 complex stabilizes the front-rear polarization of migratory cells, thereby stimulating 
persistent and chemotactic migration. Meanwhile, in epithelial cells it controls the establishment of 
apical-basal polarity, thus showing the control of distinct forms of cellular polarity [12]. Tiam1-
mediated Rac1 signaling is vital in establishing and maintaining of cell polarity, and it localizes the 
Rac1 activity at the leading edge of the migrating cells [8]. Furthermore, impaired Tiam1 signaling 
was reported to inhibit the formation of front-rear polarization during migration thereby inhibiting 
persistent migration [12]. 
The role of syndecan-4 transmembrane proteoglycan in directional migration, which is essential 
for several physiological processes, has been identified previously [21,25,31]. Moreover, syndecan-4, 
by regulating PKCα activity, is responsible for the localization of active Rac1 in membrane 
protrusions at the leading edge of cells [21], which is necessary for persistent migration. Therefore, 
knocking-out of syndecan-4 increases the level of delocalized active Rac1 [21]. It is noteworthy that 
the direct relationship between the syndecan-4 coordinated persistent migration and the Tiam1-
mediated Rac1 activation remains unknown. Earlier, we reported that syndecan-4 binds and inhibits 
Tiam1, modulating the activity of Rac1 GTPase [24]. Thus, the syndecan-4-Tiam1 complex can 
regulate the local activity of Rac1.  
Both the total amount of Rac1-GTP and its spatial distribution is critical for cell migration. 
Pankov et al. reported that both very highly activated Rac1 and very low Rac1 activity inhibit 
migration [32]. Knocking-out of syndecan-4 results in increased Rac1-GTP level [21,25–28], thus 
syndecan-4 is involved to maintain the low basal activity of Rac1, and here we reported that 
syndecan-4 silencing decreased the migration of myoblasts. NSC23766 is a cell-permeable specific 
inhibitor of Rac1 activation by the Rac1-specific GEFs Tiam1 [29]. We hypothesized that Rac1 
inhibitor treatment can improve the migratory parameters of syndecan-4 silenced cells, but the 
specific inhibition of Rac1 activity by NSC23766 did not rescue the effects of syndecan-4, rather 
exacerbated it. As NSC23766 treatment does not restore the migratory phenotype of the syndecan-4 
knockdown cells, not only the active Rac1 level but the syndecan-4-dependent localization of Rac1 
activity is also important for the correct cell migration.  
For the effective cell migration, the establishment of a rear-front Rac1 gradient is essential. The 
syndecan-4 knockdown resulted in homogenous Tiam1 distribution, which might, in turn cause 
delocalized Rac1 activation (Figure 5). This can explain the reduced persistence and motility of 
syndecan-4 knockdown cells (Figure 5). In accordance with our observation, syndecan-4-null 
fibroblasts migrate randomly as a result of high delocalized Rac1 activity [21]. Interestingly, the 
polarized distribution of syndecan-4 was already shown during cytokinesis by its accumulation in 
the intercellular bridges during cell division [33]. Moreover, the directional persistence index of 
untreated syndecan-4 knockdown cells was similar to those of the NSC23766-treated non-transfected 
and scrambled lines; indicating that more than just the absolute amount of active Rac1 is important 
for the directionality of migration.  
In this study, Tiam1 exhibited a strong asymmetrical localization toward the leading edge in 
non-transfected and scrambled cell lines. The perinuclear accumulation of Tiam1 can also be 
observed indicating that Tiam1 localizes not only in the leading-edge protrusions but also shows 
significant accumulation in the Golgi-network in migrating cells. As with other cellular constituents, 
such as centrosomes, the Golgi-apparatus requires a leader-oriented localization for effective cell 
migration. The level of Tiam1 expression seems to be correlated with cell motility [34]. In our study, 
we detected a significantly higher signal intensity of Tiam1 in non-transfected and scrambled cell 
lines, than in the syndecan-4 silenced cells (Figure 4A). These findings may indicate increased 
expression of Tiam1 in control cell lines. Syndecan-4 silencing reduces Tiam1 signal intensity and 
abrogates the strong, asymmetrical Tiam1 gradient towards the leading edge.  
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 Figure 5. (A) Schematic representation of a migrating cell with a characteristic shape. The direction 
of migration is well defined, and the Tiam1 is asymmetrically accumulated at the leading edge 
resulting in Rac1 activation and lamellipodia formation. (B) Knocking-down of syndecan-4 resulted 
in decreased Tiam1 expression, abrogated the asymmetrical distribution of Tiam1, decreased the 
directional persistence of the movement, and decreased cell motility. Par3, Par6: Partitioning defective 
3,6; aPKC: atypical PKC; Tiam1: T-lymphoma invasion and metastasis-1;  : increase;  : decrease. 
Given the role of Tiam1 and Rac1 in cell migration, several studies have explored the prognostic 
value of Tiam1 in patients with solid tumors. High Tiam1 expression has been significantly associated 
with shorter survival and positive lymphatic metastasis in patients with malignant solid tumors, and 
Tiam1 may present a promising prognostic biomarker and an effective therapeutic target for treating 
malignancies [35]. For example, a study has shown that Tiam1 expression correlated with cell motility 
in human breast cancer cells and is required to support the motile phenotype [34]. The authors 
reported the localization of endogenous Tiam1 to the Golgi, and demonstrated the role of this in Golgi 
reorientation, suggesting that it may support motility through a mechanism that is discrete from its 
known function in leading-edge dynamics [34]. Similarly, we identified accumulation of Tiam1 in 
intracellular compartments. In accordance with these Tiam1 expression data, the syndecan-4 
knockdown cells in our model system exhibited both reduced expression of Tiam1 and reduced 
motility. 
Overall, our results indicate a critical role of syndecan-4 during myoblast migration, which may 
contribute to an exploration of the essential role of syndecan-4 in the development and regeneration 
of skeletal muscle. We hope that our findings will facilitate understanding of the mechanisms 
underlying myoblast migration during embryonic development and postnatal muscle regeneration. 
4. Materials and Methods  
4.1. Cell Culture and Plasmids 
C2C12 mouse myoblast (ATCC; Manassas, VA, USA) cultures were maintained in medium 
containing 80% high-glucose Dulbecco’s modified Eagle’s medium (4.5 g/L glucose containing 584 
mg/L glutamine and 110 mg/L pyruvate; Corning, New York, NY, USA), 20% fetal bovine serum 
(Gibco/Thermo Fisher Scientific, Waltham, MA, USA), and 65 µg/mL gentamicin (Lonza, Basel, 
Switzerland). Cells were transfected stably using shRNA (short hairpin RNA) expressing plasmids 
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(OriGene, TR513122; Rockville, MD, USA) and X-tremeGENE transfection reagent (Roche, Basel, 
Switzerland). For syndecan-4 knockdown, we applied plasmids targeting the following sequences: 
5′-GAA CTG GAA GAG AAT GAG GTC ATT CCT AA-3′ (shSDC4#1) or 5′-GCG GCG TGG TAG 
GCA TCC TCT TTG CCG TT-3′ (shSDC4#2). The scrambled plasmid targeted the 5′-GCA CTA CCA 
GAG CTA ACT CAG ATA GTA CT-3′ sequence. Selection of the transfected cells was obtained by 
adding 4 µg/mL puromycin (Sigma-Aldrich, St. Louis, MO, USA) to the culturing medium. 
4.2. Time-Lapse Imaging of Live Cells 
Live-cell imaging was carried out using the Operetta high-content imaging system with a 20× 
objective (PerkinElmer, Inc., Waltham, MA, USA). For imaging, cells were seeded in 24-well plates at 
a density of 7.5 × 103 cells/well. After 60 min, the medium was changed to a serum-reduced one to 
suppress cell division, and 24 h later the nuclei were stained with Hoechst33342 (1:2000, 1 mg/mL 
stock solution; Sigma-Aldrich), and Rac1 was inhibited by NSC23766 treatment during the 
measurement (50 µM; Tocris Bioscience, Bristol, United Kingdom). Time-lapse images were obtained 
automatically at 20 min intervals for 18 h at 37 °C and 5% CO2. 
4.3. Single-Cell Tracking of Cultured Myoblasts 
Time-lapse microscopic images were analyzed using ImageJ (National Institutes of Health, 
Bethesda, MD, USA, https://imagej.nih.gov/ij/) and CellTracker (http://celltracker.website/) software 
programs. The nuclei were tracked manually through every frame, and the x and y coordinates of the 
movement were recorded. We excluded dying, dividing, or damaged cells from the analysis. Based 
on the nuclear coordinates, the length of total path, the vectorial distance (i.e., real shift of the cell), 
and maximal distance from origin, the average and maximal speed were calculated. The 
directionality of the cell movement was described by the persistence index, which was defined by the 
ratio of the vectorial distance (the distance between the origin and the endpoint of the movement) 
and the length of total path. 
4.4. Trajectories and Wind-Rose Diagrams 
To illustrate the trajectories, the migratory tracks of the individual cells were transposed to a 
common origin using Excel DiPer Plot_At_Origin macro [36]. The wind rose plots created draw 
individual cell paths based on the x and y coordinates of the cell tracking data. 
4.5. Fluorescent Staining and Microscopy 
For fluorescent staining, cells were seeded for 24 h onto fetal bovine serum (Gibco/Thermo Fisher 
Scientific, Waltham, MA, USA) coated glass coverslips (Hirschmann Laborgeräte GmbH & Co. KG, 
Eberstadt, Germany), fixed with 4% paraformaldehyde (Molar Chemicals Kft., Halásztelek, 
Hungary) for 10 min at room temperature, permeabilized with 0.3% Tween 20 (Sigma-Aldrich, Inc., 
St. Louis, Missouri, USA), and blocked with 1% bovine serum albumin (Sigma-Aldrich) in PBS. 
Rabbit polyclonal anti-Tiam1 primary antibody (OST00085W; Invitrogen, Carlsbad, CA, USA) was 
visualized with the appropriate Alexa488-conjugated secondary antibody (Invitrogen). The nuclei 
were counterstained with Hoechst 33258 (0.01 mg/mL, Sigma-Aldrich). Epi-fluorescence images were 
obtained on a Nikon Eclipse Ti-E microscope (Nikon Instruments Inc., 1300 Walt Whitman Road 
Melville, NY 11747-3064, USA) with 40× objectives. 
4.6. Evaluation of Tiam1 Immunostaining 
The epifluorescent images were recolored as heat maps using ImageJ (National Institutes of 
Health, Bethesda, MD, USA, https://imagej.nih.gov/ij/) image analysis program (Image>Lookup 
Tables). Each pixel was colored based on the pixel intensity value (16-bit images; 0-65535 gray value) 
according to the scale bar shown in the images (the lowest intensity pixels are shown as blue; the 
highest intensity pixels are shown as red). The contours of the individual cells were drawn 
(Analyze>Analyze particles), and the average pixel intensity within the border of the cells were 
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quantified (Analyze>Measure) in the different cell lines. The intensity value of each pixel was 
measured within the selected area and the sum of the intensities was divided by the area of the cell 
to obtain the average Tiam1 intensity value of the individual cells. To measure the amount of 
variation in the pixel intensities, the standard deviation of the intensity values was also calculated in 
every cell (Analyze>Measure). 
4.7. Statistical Analysis 
Differences between groups were analyzed using a one-way ANOVA, followed by the Scheffe 
post-hoc test. GraphPad Prism 7.0 (GraphPad Software Inc., San Diego, CA, USA) was used for 
graphing and statistical analyses. The data are expressed as means + standard errors of the means. A 
p value < 0.05 was considered as significantly different. 
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